Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

77.44
BATS BZX Real-Time Price
As of 12:04pm ET
 -4.32 / -5.28%
Today’s Change
68.25
Today|||52-Week Range
131.95
-11.69%
Year-to-Date

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Biomarin Pharmaceutical Inc have a median target of 110.00, with a high estimate of 150.00 and a low estimate of 81.00. The median estimate represents a +42.05% increase from the last price of 77.44.

Analyst Recommendations

The current consensus among 19 polled investment analysts is to Buy stock in Biomarin Pharmaceutical Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.10
Sales
$441.7M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -184.72%
 
 
 
 
 
 
Growthannually -101.05%
 
 
 
 
 
 

Sales

Growthquarterly -2.29%
 
 
 
 
 
 
Growthannually 2.50%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.